Reuse Validation of an Anion Exchange Chromatography Step for Purification of Clinical-Grade Ciliary Neurotrophic Factor

ACS Symposium Series

Volumn 698, Issue , 1998, Pages 125-143

  Nigam, Somesh ^a   Ruezinsky, Gary ^a   Dugger, James ^a  

^a REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345913451     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-1998-0698.ch010     Document Type: Article

References (11)

1. Adner, N.; Sofer, G. BioPharm. 1994, 7(3), 44.
2. Seely, R.J.; Wight, H.D.; Fry, H.H.; Rudge, S.R.; Slaff, G.F. BioPharm. 1994, 7(7), 41.
3. PDA Biotechnology Task Force on Purification and Scale-up. J. Parental Science and Technology. 1992, 46(3), 87.
4. Dasarathy, Y. BioPharm. 1996, 9(10), 41.
5. Johansson, B.L. BioPharm. 1992, 5(3), 34.
6. Esber, E.C. "Points to Consider in the Purification and Testing of New Drugs and Biologicals Produced by Recombinant DNA Technology" Office of Biologics Research and Review, Center for Drugs and Biologics, 1985.
7. Petricciani, J.C.; Horaud, F. Biologicals. 1995, 23, 197.
8. Scott, T.; Melvin, E.H. Anal. Biochem. 1953, 25, 1656.
9. Laemli, U.K. Nature (London). 1970, 227, 680.
10. Bradford, M. Anal. Biochem. 1976, 72, 248.
11. Kung, V.T. et al., Anal. Biochem. 1990, 187, 220.